No Matches Found
No Matches Found
No Matches Found
Tilray Brands, Inc.
Tilray Brands, Inc. Experiences Evaluation Revision Amidst Market Dynamics and Performance Indicators
Tilray Brands, Inc. has recently revised its evaluation amid changing market conditions. The stock, priced at $1.58, has shown significant volatility over the past year, with a high of $1.88 and a low of $0.35. Its performance has varied compared to the S&P 500, with notable short-term gains.
Is Tilray Brands, Inc. technically bullish or bearish?
As of October 3, 2025, Tilray Brands, Inc. has shifted to a bullish trend, supported by positive weekly MACD and moving averages, despite underperforming the S&P 500 over the past 1, 3, and 5 years.
Is Tilray Brands, Inc. technically bullish or bearish?
As of October 3, 2025, Tilray Brands, Inc. shows a bullish technical trend with strong short-term performance, having outperformed the S&P 500 recently, but long-term returns remain significantly negative.
Is Tilray Brands, Inc. technically bullish or bearish?
As of October 3, 2025, Tilray Brands, Inc. has shifted to a bullish technical trend, supported by positive momentum indicators, strong short-term performance, and significant outperformance against the S&P 500, despite negative long-term returns.
Tilray Brands Hits Day High with 45.38% Surge in Strong Intraday Performance
Tilray Brands, Inc. has seen notable trading activity, with its stock reaching an intraday high. The company has demonstrated significant weekly and year-to-date gains, contrasting with the S&P 500's performance. However, it faces challenges, including a negative return on equity and a history of underperformance against the index.
Is Tilray Brands, Inc. technically bullish or bearish?
As of September 5, 2025, Tilray Brands, Inc. shows a mildly bullish trend with positive weekly momentum, but mixed signals in longer timeframes suggest caution, especially given its negative one-year return compared to the S&P 500.
Is Tilray Brands, Inc. overvalued or undervalued?
As of March 18, 2019, Tilray Brands, Inc. is considered a risky investment due to its overvaluation, evidenced by a lack of P/E ratio, a low Price to Book Value of 0.15, and a high EV to EBITDA of 29.32, alongside a 1-year stock return of -30.00% compared to the S&P 500's 17.14%.
Is Tilray Brands, Inc. overvalued or undervalued?
As of March 18, 2019, Tilray Brands, Inc. is considered overvalued and risky, with a price to book value of 0.15, an EV to EBITDA of 29.32, a negative ROCE of -4.19%, and a year-to-date return of -72.89%, significantly underperforming compared to its peers and the S&P 500.
Is Tilray Brands, Inc. technically bullish or bearish?
As of January 8, 2025, Tilray Brands, Inc. is in a bearish trend with moderate strength, driven by bearish daily moving averages and Dow Theory, despite some mildly bullish signals from the MACD, while underperforming the S&P 500.
Who are in the management team of Tilray Brands, Inc.?
As of March 2022, the management team of Tilray Brands, Inc. includes Brendan Kennedy (Director), Michael Auerbach, Rebekah Dopp, Soren Schroder, and Christine St.Clare, all serving as independent directors.
What does Tilray Brands, Inc. do?
Tilray Brands, Inc. operates in the pharmaceutical sector, focusing on cannabis products and medical cannabis research, cultivation, and distribution. As of February 2025, it reported net sales of $186 million and a net loss of $794 million, with a market cap of $394.01 million.
How big is Tilray Brands, Inc.?
As of Jun 18, Tilray Brands, Inc. has a market capitalization of 394.01 million, with net sales of 826.65 million and a net profit of -928.84 million over the latest four quarters. The company reported shareholder's funds of 3,442.91 million and total assets of 4,335.30 million as of May 24.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
